Heidelberg Engineering GmbH
Germany DE-MF-000008127 Last updated 23 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 25
- Registries
- EUDAMEDFDA 510(k)GUDIDFDA
- FDA recalls
- 31 ongoing
Catalogue
Ashvins variant HEYEX 2 / HEYEX PACS Ref 5012937
Spectralis Ref 600300
Anterion Ref K261019
Ashvins variant Ashvins Diagnostic Workstation Ref 5012936
Ashvins variant Ashvins Web Extreme Ref 5012939
Ashvins Ref 5012938
Spectralis Ref 4002968
SPECTRALIS Platform Ref 88033
SPECTRALIS HRA+OCT and variants Ref K240221
Spectralis HRA+OCT and variants Ref K201252
Spectralis HRA+OCT and Variants Ref K192391
SPECTRALIS with Flex Module Ref K241163
SPECTRALIS HRA+OCT and variants Ref K250868
SPECTRALIS HRA+OCT and variants Ref K223557
Spectralis HRA + OCT and variants Ref K173648
Anterion Ref 88036
TomoCaps Ref 18829
ANTERION Software Ref 4001670
EUDAMED certificates
TÜV SÜD Product Service GmbH 0123 1 certificate
- G15 106871 0008 Supplemented
Quality management system EU MDR
- Issued
- 9 Jun 2026
- Expires
- 17 Dec 2030
- Reason
- Add device or group
Related companies
Notified bodies
FDA recalls
Heidelberg Engineering GmbH has one FDA recall record initiated on December 8, 2017, which is marked as terminated. The recall was related to the SPECTRALIS Widefield OCT feature, where FDA notified the company that a 510(k) clearance was required and instructed customers to discontinue use pending submission of a new 510(k) filing on November 27, 2017.
2026
- 6 Aug 2026 Z-3215-2026 Class II Ongoing Wheels may come loose when module is being pushed or pulled during movement or transportation, affecting stability of the stand. The stand may tip over as a result. Falling stand may cause impact or crushing injuries, particularly to the feet, legs, hands or arms of the operator or nearby persons.
2019
- 3 Jul 2019 Z-2437-2019 Class II Terminated Error in the default configuration which could lead to the incorrect display of patient master data.
2017
- 8 Dec 2017 Z-1535-2018 Class II Terminated FDA notified Heidelberg Engineering that a 510(k) clearance is needed for the SPECTRALIS Widefield OCT feature, and, on November 27, 2017, Heidelberg Engineering submitted a new 510(k) for this feature. FDA has asked Heidelberg Engineering to instruct customers not to use the Widefield OCT software feature on the SPECTRALIS device until 510(k) clearance has been obtained for this software feature.
What Heidelberg Engineering GmbH makes
Heidelberg Engineering GmbH manufactures retinal imaging systems under the SPECTRALIS platform, including confocal scanning laser ophthalmoscopes (HRA) combined with optical coherence tomography (OCT). Key variants include systems with Fluorescein Angiography (FA+OCT), Indocyanine Green Angiography (ICGA+OCT), OCT Blue Peak, and Multicolor imaging, as well as specialized modules like the Anterior Segment Module (ASM) and High Magnification Module. Additional features include OCT Angiography and a Flex Module for extended field-of-view imaging.
The company’s devices are classified as Class II, IIa, and IIb under EU regulations and are listed in the EUDAQS (eudamed) registry. They are also documented in the FDA’s 510(k) database for market authorization in the United States. The manufacturer is based in Germany.
Frequently asked questions
What types of medical devices does Heidelberg Engineering GmbH manufacture?
Heidelberg Engineering GmbH specializes in retinal imaging systems under the SPECTRALIS platform. These devices combine confocal scanning laser ophthalmoscopy (HRA) with optical coherence tomography (OCT) to capture detailed images of the retina. Key variants include systems with Fluorescein Angiography (FA+OCT), Indocyanine Green Angiography (ICGA+OCT), OCT Blue Peak, and Multicolor imaging, as well as specialized modules like the Anterior Segment Module (ASM) and High Magnification Module. Some models also feature OCT Angiography and a Flex Module for extended field-of-view imaging.
Where is Heidelberg Engineering GmbH based?
Heidelberg Engineering GmbH is headquartered in Germany, specifically in Heidelberg. The company’s location influences its regulatory compliance framework, particularly for devices marketed in the European Economic Area (EEA).
Which regulatory registries list Heidelberg Engineering GmbH’s devices?
Heidelberg Engineering GmbH’s devices are documented in EUDAQS (eudamed), the European Union’s database for medical devices. Additionally, their products are listed in the FDA’s 510(k) database, reflecting their market authorization in the United States. These registries ensure transparency for regulatory oversight and device traceability.
How are Heidelberg Engineering GmbH’s devices classified under EU regulations?
The company’s devices fall under Class II, IIa, and IIb classifications in the EU. This classification is determined by factors like the device’s intended use, risk level, and potential impact on patient health. Class II devices require conformity assessment procedures (e.g., clinical evaluations, technical documentation reviews) to demonstrate safety and performance before market placement, as outlined in EU MDR/IVDR regulations.
Why are some of Heidelberg Engineering GmbH’s devices listed in the FDA’s 510(k) database?
The FDA’s 510(k) database includes devices that have undergone a 510(k) premarket notification process to demonstrate substantial equivalence to a legally marketed predicate device in the U.S. This pathway is used for Class II devices (like those from Heidelberg Engineering) to ensure they meet FDA safety and effectiveness requirements before commercial distribution in the United States. Listing in this database confirms regulatory clearance for market authorization.
Information
- Country
- Germany
- Address
- Max-Jarecki-Str. 8, HEIDELBERG Baden-Wurttemberg
- Website
- heidelbergengineering.com
- [email protected]
- PRRC contact
- Frank Müller
- EUDAMED SRN
- DE-MF-000008127
- FDA FEI number
- 3002807157
- DUNS number
- 329833875